• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个针对罗苏伐他汀血药浓度变异性的非洲特有的药物基因变异体谱:SLCO1B1 c.521T>C 和 ABCG2 c.421A>C 的作用有限。

An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.

机构信息

Division of Human Genetic, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

African Institute of Biomedical Science and Technology (AiBST), Wilkins Hospital, Corner Rekai Tangwena and Josiah Tongogara Ave, Harare, Zimbabwe.

出版信息

Pharmacogenomics J. 2019 Jun;19(3):240-248. doi: 10.1038/s41397-018-0035-3. Epub 2018 Aug 13.

DOI:10.1038/s41397-018-0035-3
PMID:30100615
Abstract

Studies in Caucasian and Asian populations consistently associated interindividual and interethnic variability in rosuvastatin pharmacokinetics to the polymorphisms SLCO1B1 c.521T>C (rs4149056 p. Val174Ala) and ABCG2 c.421C>A (rs2231142, p. Gln141Lys). To investigate the pharmacogenetics of rosuvastatin in African populations, we first screened 785 individuals from nine ethnic African populations for the SLCO1B1 c.521C and ABCG2 c.421CA variants. This was followed by sequencing whole exomes from individuals of African Bantu descent, who participated in a 20 mg rosuvastatin pharmacokinetic trial in Harare Zimbabwe. Frequencies of SLCO1B1 c.521C ranged from 0.0% (San) to 7.0% (Maasai), while ABCG2 c.421A ranged from 0.0% (Shona) to 5.0% (Kikuyu). Variants showing significant association with rosuvastatin exposure were identified in SLCO1B1, ABCC2, SLC10A2, ABCB11, AHR, HNF4A, RXRA and FOXA3, and appear to be African specific. Interindividual differences in the pharmacokinetics of rosuvastatin in this African cohort cannot be explained by the polymorphisms SLCO1B1 c.521T>C and ABCG2 c.421C>A, but appear driven by a different set of variants.

摘要

在白种人和亚洲人群中的研究一致表明,洛伐他汀药代动力学的个体间和种族间变异性与 SLCO1B1 c.521T>C(rs4149056 p.Val174Ala)和 ABCG2 c.421C>A(rs2231142,p.Gln141Lys)多态性有关。为了研究洛伐他汀在非洲人群中的药物遗传学,我们首先在来自九个非洲种族群体的 785 个人中筛选了 SLCO1B1 c.521C 和 ABCG2 c.421CA 变体。随后,对来自非洲班图人的个体进行了全外显子测序,他们参加了在津巴布韦哈拉雷进行的 20mg 洛伐他汀药代动力学试验。SLCO1B1 c.521C 的频率范围从 0.0%(桑人)到 7.0%(马赛人),而 ABCG2 c.421A 的频率范围从 0.0%(绍纳人)到 5.0%(基库尤人)。在 SLCO1B1、ABCC2、SLC10A2、ABCB11、AHR、HNF4A、RXRA 和 FOXA3 中发现了与洛伐他汀暴露显著相关的变体,这些变体似乎是非洲特有的。在这个非洲队列中,洛伐他汀药代动力学的个体间差异不能用 SLCO1B1 c.521T>C 和 ABCG2 c.421C>A 多态性来解释,但似乎是由一组不同的变体驱动的。

相似文献

1
An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.一个针对罗苏伐他汀血药浓度变异性的非洲特有的药物基因变异体谱:SLCO1B1 c.521T>C 和 ABCG2 c.421A>C 的作用有限。
Pharmacogenomics J. 2019 Jun;19(3):240-248. doi: 10.1038/s41397-018-0035-3. Epub 2018 Aug 13.
2
Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.瑞舒伐他汀在美国居住的白种人和亚洲人群中的药代动力学与药物遗传学
Eur J Clin Pharmacol. 2015 Mar;71(3):329-40. doi: 10.1007/s00228-014-1800-0. Epub 2015 Jan 30.
3
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.SLCO1B1(c.521T>C,rs4149056)和 ABCG2(c.421C>A,rs2231142)基因的功能丧失多态性与瑞舒伐他汀的不良事件相关:一项病例对照研究。
Eur J Clin Pharmacol. 2022 Feb;78(2):227-236. doi: 10.1007/s00228-021-03233-7. Epub 2021 Oct 19.
4
Effects of Polymorphisms in NR1H4, NR1I2, SLCO1B1, and ABCG2 on the Pharmacokinetics of Rosuvastatin in Healthy Chinese Volunteers.NR1H4、NR1I2、SLCO1B1和ABCG2基因多态性对健康中国志愿者中瑞舒伐他汀药代动力学的影响。
J Cardiovasc Pharmacol. 2016 Nov;68(5):383-390. doi: 10.1097/FJC.0000000000000426.
5
Effects of ABCG2 and SLCO1B1 gene variants on inflammation markers in patients with hypercholesterolemia and diabetes mellitus treated with rosuvastatin.ABCG2 和 SLCO1B1 基因变异对瑞舒伐他汀治疗的高胆固醇血症和糖尿病患者炎症标志物的影响。
Eur J Clin Pharmacol. 2020 Jul;76(7):939-946. doi: 10.1007/s00228-020-02882-4. Epub 2020 May 2.
6
Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?ABCG2和SLCO1B1基因多态性对高加索人和亚洲人瑞舒伐他汀、阿托伐他汀及辛伐他汀酸药代动力学的影响:类效应?
Eur J Clin Pharmacol. 2015 Mar;71(3):341-55. doi: 10.1007/s00228-014-1801-z. Epub 2015 Feb 12.
7
Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects.OATP1B1 和 BCRP 多态性对老年和年轻韩国受试者中瑞舒伐他汀药代动力学和药效学的影响。
Sci Rep. 2019 Dec 19;9(1):19410. doi: 10.1038/s41598-019-55562-4.
8
Explaining Ethnic Variability of Transporter Substrate Pharmacokinetics in Healthy Asian and Caucasian Subjects with Allele Frequencies of OATP1B1 and BCRP: A Mechanistic Modeling Analysis.解释健康亚洲和高加索人群中 OATP1B1 和 BCRP 等位基因频率的转运体底物药代动力学的种族变异性:一种机制建模分析。
Clin Pharmacokinet. 2018 Apr;57(4):491-503. doi: 10.1007/s40262-017-0568-7.
9
Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions.在 OATP1B1 和 BCRP 均为野生型的亚洲和白人受试者中,瑞舒伐他汀在对照和抑制条件下的药代动力学。
J Pharm Sci. 2017 Sep;106(9):2751-2757. doi: 10.1016/j.xphs.2017.03.027. Epub 2017 Apr 3.
10
Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote.ABCG2 34G>A和421C>A纯合子或复合杂合子的健康中国人体内瑞舒伐他汀药代动力学的显著改变
J Pharmacol Exp Ther. 2015 Sep;354(3):310-5. doi: 10.1124/jpet.115.225045. Epub 2015 Jun 16.

引用本文的文献

1
Towards Evidence-Based Implementation of Pharmacogenomics in Southern Africa: Comorbidities and Polypharmacy Profiles across Diseases.迈向南部非洲基于证据的药物基因组学实施:跨疾病的合并症和多药治疗情况
J Pers Med. 2023 Jul 26;13(8):1185. doi: 10.3390/jpm13081185.
2
Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.华法林药物基因组学在南非真实临床实践中的精准医学应用:利用 29 个药物基因中的 73 个变异体。
OMICS. 2022 Jan;26(1):35-50. doi: 10.1089/omi.2021.0199. Epub 2021 Dec 24.
3
Late response to rosuvastatin and statin-related myalgia due to , , , and variants in a patient with Familial Hypercholesterolemia: a case report.

本文引用的文献

1
Involvement of hepatocyte nuclear factor 4alpha in the different expression level between CYP2C9 and CYP2C19 in the human liver.肝细胞核因子4α与人肝脏中CYP2C9和CYP2C19表达水平差异的关系。
Drug Metab Dispos. 2006 Jun;34(6):1012-8. doi: 10.1124/dmd.106.009365. Epub 2006 Mar 15.
家族性高胆固醇血症患者中因、、、和变体导致的瑞舒伐他汀迟发性反应及他汀类药物相关性肌痛:一例报告
Ann Transl Med. 2021 Jan;9(1):76. doi: 10.21037/atm-20-5540.
4
Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review.撒哈拉以南非洲地区实施临床药物遗传学检测的障碍。一项批判性综述。
Pharmaceutics. 2020 Aug 26;12(9):809. doi: 10.3390/pharmaceutics12090809.
5
African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa.非洲药物基因组学联盟:巩固非洲的药物基因组学知识、能力发展与转化:巩固非洲的药物基因组学知识、能力发展与转化。
AAS Open Res. 2019 Jun 4;2:19. doi: 10.12688/aasopenres.12965.1. eCollection 2019.